News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
303,127 Results
Type
Article (15805)
Company Profile (118)
Press Release (287204)
Section
Business (97253)
Career Advice (724)
Deals (16419)
Drug Delivery (73)
Drug Development (38962)
Employer Resources (92)
FDA (6718)
Job Trends (7084)
News (163403)
Policy (14664)
Tag
Academia (716)
Alliances (25961)
Alzheimer's disease (518)
Approvals (6724)
Artificial intelligence (121)
Bankruptcy (147)
Best Places to Work (5170)
Breast cancer (107)
Cancer (616)
Cardiovascular disease (64)
Career advice (632)
Cell therapy (87)
Clinical research (32416)
Collaboration (323)
Compensation (106)
COVID-19 (862)
C-suite (89)
Data (610)
Diabetes (80)
Diagnostics (2186)
Drug pricing (65)
Earnings (33886)
Employer resources (80)
Events (43151)
Executive appointments (304)
FDA (7042)
Funding (204)
Gene therapy (91)
GLP-1 (333)
Government (1405)
Healthcare (5214)
Infectious disease (896)
Inflammatory bowel disease (59)
Interviews (97)
IPO (6400)
Job creations (2123)
Job search strategy (543)
Layoffs (181)
Legal (3489)
Lung cancer (81)
Manufacturing (121)
Medical device (2265)
Medtech (2268)
Mergers & acquisitions (10140)
Metabolic disorders (245)
Neuroscience (675)
NextGen: Class of 2025 (2115)
Non-profit (1080)
Northern California (729)
Obesity (148)
Opinion (131)
Patents (73)
People (32330)
Pharmaceutical (68)
Phase I (8626)
Phase II (13749)
Phase III (12144)
Pipeline (269)
Podcasts (65)
Postmarket research (1465)
Preclinical (3490)
Radiopharmaceuticals (123)
Rare diseases (132)
Real estate (2759)
Regulatory (10445)
Research institute (879)
Resumes & cover letters (83)
Southern California (659)
Startups (1810)
United States (6750)
Vaccines (144)
Weight loss (93)
Date
Today (52)
Last 7 days (194)
Last 30 days (911)
Last 365 days (15544)
2025 (817)
2024 (15734)
2023 (17384)
2022 (25312)
2021 (26435)
2020 (24044)
2019 (19002)
2018 (14470)
2017 (15382)
2016 (14561)
2015 (16928)
2014 (13346)
2013 (11255)
2012 (12103)
2011 (12593)
2010 (11378)
Location
Africa (358)
Arizona (55)
Asia (21342)
Australia (2833)
California (1660)
Canada (781)
China (179)
Colorado (67)
Connecticut (91)
Europe (44092)
Florida (245)
Illinois (176)
Indiana (120)
Japan (63)
Kansas (55)
Maryland (233)
Massachusetts (1366)
Minnesota (90)
New Jersey (594)
New York (491)
North Carolina (393)
Northern California (729)
Ohio (56)
Pennsylvania (394)
South America (546)
Southern California (659)
Texas (230)
Washington State (144)
303,127 Results for "insight pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
A Conversation with Peter Marks: Insights into GenScript Biotech Forum 2025
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis talks to Dr. Peter Marks, Director, CBER about his thoughts on the future of cell and gene therapies.
January 16, 2025
·
1 min read
·
Lori Ellis
Business
A Conversation with Peter Marks and Tom Whitehead: Insights into GenScript Biotech Forum 2025 (Teaser)
In this short teaser, BioSpace’s Head of Insights Lori Ellis talks to CBER Director Peter Marks and Tom Whitehead, Co-Founder of the Emily Whitehead Foundation about anticipated discussions at the upcoming GenScript Biotech Forum.
January 10, 2025
·
1 min read
·
Lori Ellis
Business
Investing in AI: Benefits, Regulatory Challenges
In this episode of Denatured, BioSpace’s Head of Insights Lori and guests from Teva Pharmaceuticals and TOWER Capital discuss the opportunities, regulatory challenges and uncertainty surrounding AI.
November 7, 2024
·
1 min read
·
Lori Ellis
Business
51%: The Untapped Market
In this episode of Denatured, BioSpace’s Head of Insights Lori and guests from Teva Pharmaceuticals and TOWER Capital Group discuss how critical it is to incorporate women into leadership positions and board rooms as a sound investment strategy.
November 21, 2024
·
1 min read
·
Lori Ellis
Business
Trials and Capital: Women’s Health and APAC’s Healthcare Revolution
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis, Miguel Forte and Ali Pashazadeh discuss the industry’s need to catch up with women’s health issues and the innovative lead the APAC region has taken in clinical trials.
January 2, 2025
·
1 min read
·
Lori Ellis
Press Releases
Global Single Cell Multiomics Market Size/Share and Future Growth Forecast 2025-2035 : Key Insights by Custom Market Insights
January 21, 2025
·
1 min read
Press Releases
Patient Enrolment Completed for INSIGHT-003
January 6, 2025
·
2 min read
Business
Analysis vs Beliefs, CEO Challenges, GLP-1 Investments
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis, Miguel Forte and Ali Pashazadeh speculate on the impending Trump administration, discuss current challenges faced by CEOs and weigh investment in GLP-1s.
December 19, 2024
·
1 min read
·
Lori Ellis
Business
Previous Investment Patterns Set to Repeat in 2025
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis, Miguel Forte and Ali Pashazadeh discuss how a slow and steady pace is a continuation of the pattern we have seen throughout the last three years.
December 5, 2024
·
1 min read
·
Lori Ellis
Press Releases
PROTAC Targeted Protein Degraders Clinical Trials Insight
December 13, 2024
·
1 min read
1 of 30,313
Next
